Please complete the CAPTCHA to continue
@oncomyx.com
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Leslie Sharp is listed as Biopharma Oncology R&D Executive at Pantherin Consulting, Inc., based in San Diego, California, United States. AeroLeads shows a work email signal at oncomyx.com and a matched LinkedIn profile for Leslie Sharp.
Leslie Sharp previously worked as President at Pantherin Consulting, Inc. and Chief Scientific Officer at Oncomyx Therapeutics. Leslie Sharp holds Phd, Biology from Uc San Diego.
This section adds company-level context without repeating Leslie Sharp's masked contact details.
AeroLeads found 1 current-domain work email signal for Leslie Sharp. Compare company email patterns before reaching out.
Accomplished pharmaceutical/biotech industry scientific and strategic leader with extensive experience in drug discovery and development. In depth knowledge of drug discovery ranging from idea through Phase 1. Specific expertise in biological therapeutics and cancer immunotherapy agents. Track record of building high performing teams and delivering results. Highly motivated leader capable of effectively working in dynamic multi-disciplinary teams.Expertise in: Oncology, Immunology, Cancer Immunotherapy, Target Selection/Validation, Pharmacology, Biomarker Development, Project Leadership, Portfolio Management, Biological Therapeutics, Antibody Drug Conjugates
Listed skills include Oncology, Drug Discovery, Immunology, Translational Research, and 18 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Providing consulting services for the Life Sciences, Biotechnology, and Pharmaceutical industries serving both small and large sized organizations. Particular expertise in biological therapeutics and cancer immunotherapy agents.Specific deliverables include:- Strategy development and scientific portfolio recommendations- Project plans and leadership.
Phoenix, AZ, US
OncoMyx Therapeutics is developing oncolytic immunotherapies based on the myxoma virus (MYXV) platform to orchestrate an immune response and treat cancer. Our therapeutic platform includes several best-in-class features. Our pipeline includes both monotherapies and therapies to be used in combination with immune checkpoint blockade and other.
San Diego, California, US
Vice President, Immuno-Oncology Jan 2017-April 2019Director, Immuno-Oncology June 2015-Jan-2017Responsible for strategy development, portfolio management, and experimental execution to enable therapeutic program progression from target identification through first in human studies for oncology drug discovery including antibody and antibody drug conjugates.
San Diego, CA, US
Strategy development, portfolio management, and experimental execution to enable therapeutic program progression from target identification through candidate selection for oncology drug discovery including low molecular weight entities, antibody and antibody drug conjugates (ADC), and cancer immunotherapy agentsInitiate and manage external collaborations.
New York, New York, US
Strategy development and experimental execution to enable identification and validation of new targets within the breast, ovarian, and prostate cancer disease biology spaceMember of internal governance board responsible for oversight of early research portfolio projectsInitiate and manage external collaborations with field key opinion leaders Directly.
New York, New York, US
Research Project Leader, responsible for leading multifunctional, cross-site research project team to enable decision making necessary for progression of oncology monoclonal antibody projects through stage gate transitions including IND submissionInitiated and managed external collaborations including review of experimental design and data quality.
New York, New York, US
Responsible for design and execution of in vitro and in vivo preclinical pharmacology and biomarker experiments for oncology monoclonal antibody programs with antibody dependent cellular cytotoxicity (ADCC) mechanism of action
Developed in vitro assays to evaluate the differentiation potential of stem cellsDesign and oversight of in vivo preclinical safety and efficacy studiesFormulated and implemented plans for process development internally and with a contract manufacturing organization Biological Safety Officer with responsibility for in house training programs and.
Quick answers generated from the profile data available on this page.
Leslie Sharp works for Pantherin Consulting, Inc..
Leslie Sharp is listed as Biopharma Oncology R&D Executive at Pantherin Consulting, Inc..
AeroLeads has found 1 work email signal at @oncomyx.com for Leslie Sharp at Pantherin Consulting, Inc..
Leslie Sharp is based in San Diego, California, United States while working with Pantherin Consulting, Inc..
Leslie Sharp has worked for Pantherin Consulting, Inc., Oncomyx Therapeutics, Bioatla Llc, Genomics Institute Of The Novartis Research Foundation (Gnf), and Pfizer.
You can use AeroLeads to view verified contact signals for Leslie Sharp at Pantherin Consulting, Inc., including work email, phone, and LinkedIn data when available.
Leslie Sharp holds Phd, Biology from Uc San Diego.
Leslie Sharp is listed with skills including Oncology, Drug Discovery, Immunology, Translational Research, Drug Development, Biotechnology, Cell Biology, and Life Sciences.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts